Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 29:23969873251379985.
doi: 10.1177/23969873251379985. Online ahead of print.

Optic nerve sheath diameter for prediction of intracranial hypertension after ischemic sTrokE - The ONSITE study

Affiliations

Optic nerve sheath diameter for prediction of intracranial hypertension after ischemic sTrokE - The ONSITE study

Philipp Baumgartner et al. Eur Stroke J. .

Abstract

Background: Intracranial hypertension (IH) from brain edema is a life-threatening complication of large vessel occlusion (LVO) stroke, yet clinical monitoring is often unreliable. Non-invasive methods for early IH prediction are needed. This study assessed whether sonographic measurement of the optic nerve sheath diameter (ONSD) could improve the prediction of IH after stroke.

Patients and methods: We prospectively measured the internal optic nerve sheath diameter (ONSDint) via transorbital ultrasound in 65 stroke patients and 30 controls. ONSD was also measured on the initial CT or MRI. The primary endpoint of IH was a composite of clinical and radiological signs of brain swelling. A predictive ONSD cut-off was determined from a multivariable logistic regression model, adjusted for age and infarct volume. Predictive performance was assessed using leave-one-out cross-validation.

Results: Seven of 65 stroke patients (11%) developed IH. The initial sonographic ONSDint was significantly increased in patients who developed IH. The multivariable model identified an optimal predictive cut-off of ⩾5.51 mm, which predicted IH with a sensitivity of 85.7% and a specificity of 94.8%. In comparison, ONSD derived from initial neuroimaging was also a strong predictor, with an optimal cut-off of 6.80 mm yielding a sensitivity of 100% and a specificity of 91.1%, and showed superior predictive accuracy in the cross-validation (AUC 0.905 vs 0.687).

Discussion: Our sonographic ONSDint cut-off of ≥5.51 mm aligns well with recent stroke literature that used similar standardized measurement techniques. Our findings also highlight the distinct roles of different imaging modalities. While the initial CT/MRI provides a static measurement with high predictive power, the unique advantage of sonography is its bedside applicability, allowing for the crucial, non-invasive serial monitoring of ONSD as a dynamic marker of intracranial pressure changes.

Conclusion: Early ONSD assessment is a valuable predictor of IH after severe stroke. A sonographic ONSDint of ⩾5.51 mm identifies patients at high risk with excellent accuracy. While initial neuroimaging may offer superior predictive power, bedside sonography remains a crucial, repeatable tool for monitoring these critically ill patients.

Keywords: Ischemic stroke; intracranial hypertension; intracranial pressure; large vessel occlusion stroke; malignant media infarction; optic nerve sheath; optic nerve sheath diameter; ultrasound.

PubMed Disclaimer

Conflict of interest statement

The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: PB: Research funds by the Gottfried and Julia Bangerter-Rhyner Foundation and Swiss Academy of Medical Sciences and funding for travel and conference fees from BMS/Pfizer and Novo Nordisk. SW: received research funds by the Swiss National Science Foundation, the UZH Clinical research priority program (CRPP) stroke, the Zurich Neuroscience Center (ZNZ), the Baugarten foundation, the Hartmann Müller Foundation, the Koetser Foundation, the Swiss Heart Foundation; and speaker honoraria from Amgen, Springer, Advisis AG, Teva Pharma, Boehringer Ingelheim, Lundbeck, Astra Zeneca, FoMF, and a consultancy fee from Bayer and Novartis via institution for research.

Figures

Graphical abstract
Graphical abstract
Image A shows a transorbital sonography probe being applied to a patient’s eye, B depicts an ultrasound image measuring optic nerve sheath diameter with calipers, C is an axial CT scan illustrating the same measurement.
Figure 1.
Standardized Measurement of the Optic Nerve Sheath Diameter (ONSD): (a) application of the high-frequency linear probe for transorbital sonography, (b) ultrasound image demonstrating the measurement of the internal ONSD (ONSDint, light blue dashed line) 3 mm posterior to the globe. The white calipers indicate the measurement of the external ONSD, and (c) corresponding ONSD measurement on an axial CT scan.
The image is a flowchart detailing patient inclusion in clinical study. It shows 108 patients initially, with exclusion details leading to the final 95 patients in the study.
Figure 2.
Flow chart of included and excluded patients.
Stroke ONSD results at specified moments. ONSD-int vs. contralateral; includes error bars. Dashed line denotes control group mean.
Figure 3.
Longitudinal ONSDint measurements after stroke. Mean ONSDint is plotted for the ipsilateral and contralateral eye at six time points after stroke onset. Error bars represent the standard error of the mean. The dashed horizontal line indicates the mean ONSDint of the non-stroke control group (4.66 mm).
The content is about a medical study on cerebral edema in stroke patients, and the alt text for the image should describe a scientific figure. Here is an appropriate alt text for the image provided: Longitudinal optical coherence tomography imaging shows the effects of mild-to-moderate and severe cerebral edema after stroke over time.
Figure 4.
Longitudinal ONSDint by grade of cerebral edema: (a) mean ONSDint at six time points after stroke onset for patients with no edema (white bars), mild-to-moderate edema (gray bars), and severe edema (dark gray bars). Error bars represent the standard error of the mean, (b–d) representative MRI FLAIR images of a patient with no edema (b), mild-to-moderate edema (c), and severe edema with midline shift (d).
Predictive performance of ONSD for intracranial hypertension. ROC curves from the leave-one-out cross-validation. (a) The model including sonography-derived ONSDint (red line) compared to the baseline model without ONSD (blue line). (b) The model including CT/MRI-derived ONSD (red line) showed a substantial improvement in predictive performance compared to the baseline model. AUC values are provided with 95% confidence intervals.
Figure 5.
Predictive performance of ONSD for intracranial hypertension. Receiver Operating Characteristic (ROC) curves from the leave-one-out cross-validation. (a) The model including sonography-derived ONSDint (red line) compared to the baseline model without ONSD (blue line). (b) The model including CT/MRI-derived ONSD (red line) showed a substantial improvement in predictive performance compared to the baseline model. AUC values are provided with 95% confidence intervals.

References

    1. Hofmeijer J, Algra A, Kappelle LJ, et al. Predictors of life-threatening brain edema in middle cerebral artery infarction. Cerebrovasc Dis 2008; 25: 176–184. - PubMed
    1. Hacke W, Schwab S, Horn M, et al. ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996; 53: 309–315. - PubMed
    1. Heiss W-D. Malignant MCA infarction: pathophysiology and imaging for early diagnosis and management decisions. Cerebrovasc Dis 2016; 41: 1–7. - PubMed
    1. Wijdicks EF, Sheth KN, Carter BS, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 1222–1238. - PubMed
    1. Ropper AH, Shafran B. Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol 1984; 41: 26–29. - PubMed

LinkOut - more resources